← FDA DRUG APPROVALS

FDA ANDA · ANDA090962

ADAPALENE

Sponsor: P AND L

APPLICATION
ANDA090962
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-02
LATEST ACTION
2026-03-10
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Over-the-counter

Products

ADAPALENEOver-the-counter
ADAPALENE 0.1% · GEL · TOPICAL

Approval history

2026-03-10Manufacturing (CMC) · Supplement 8 · unknownAP
2019-07-08Manufacturing (CMC) · Supplement 5 · unknownAP
2010-06-02OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →